¹Ì±¹ÀÇ ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¼­ºñ½ºº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
U.S. Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Services, By End Use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1587418
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 110 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹ÀÇ ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 50¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.5%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇコÄÉ¾î »ê¾÷ÀÇ ±â¼ú ¹ßÀü°ú ÃÖÁ¾»ç¿ëÀÚ Áõ°¡°¡ ¹Ì±¹ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù.

ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½ÌÀ» ÅëÇØ ±â¾÷Àº º¸´Ù º¹ÀâÇÑ ¾÷¹«¿Í ¹Ýº¹ÀûÀÎ ¾÷¹«¸¦ ó¸®ÇÒ ¼ö ÀÖÀ¸¸ç, µ¿½Ã¿¡ ÇÙ½É ¿ª·®¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á±â°üÀº Àü¹® ½Ã¼³ °³¹ß ¹× Á÷¿ø °í¿ëÀ» ÇÇÇÒ ¼ö ÀÖ¾î ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀǾàǰ ¹× Ä¡·á ¿ë¾×¿¡ Æ÷ÇÔµÈ ¼ººÐÀÇ ½Äº° ¹× ÃøÁ¤Àº ÀǾàǰ ºÐ¼® ½ÃÇè¿¡ Æ÷ÇԵ˴ϴÙ. ¿¬±¸ °³¹ß ÅõÀÚ Áõ°¡¿Í ÀǾàǰ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº Æò°¡ ±â°£ µ¿¾È È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½ÌÀº COVID-19 »çÅ·ΠÀÎÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¿©·¯ Á¦¾àȸ»çÀÇ »ç³» ½ÇÇè½Ç °Ë»ç ´É·ÂÀÌ Ãà¼ÒµÇ°Å³ª ÁߴܵǸ鼭 ÀÇ·á ÀÎÇÁ¶óÀÇ Áß¿äÇÑ ±¸¼º¿ä¼ÒÀÎ ÀǾàǰ ºÐ¼® ¼­ºñ½º´Â óÀ½¿¡ ÁߴܵǾú½À´Ï´Ù. Á÷¿øµéÀº Ãʱ⿡´Â ¹ÙÀÌ·¯½º È®»ê ¿ì·Á·Î ÀÎÇÑ ½ÇÇè½Ç ¿ë·® °¨¼Ò, IT ¹®Á¦, °Ë»ç¸¦ À§ÇÑ »ùÇà Àü¼ÛÀÇ ¾î·Á¿ò µî ¿©·¯ °¡Áö ¾î·Á¿ò¿¡ Á÷¸éÇß½À´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ¾î·Á¿òÀ» ¿ÏÈ­Çϰųª ¹æÁöÇϱâ À§ÇØ ±³´ë ±Ù¹«, Àη °¨Ãà, ÀçÅà ±Ù¹« µî ´Ù¾çÇÑ Àü·«À» äÅÃÇß½À´Ï´Ù.

´Ù¾çÇÑ ±â¾÷µéÀÌ ´Ù¾çÇÑ Ã·´Ü °Ë»ç ¹× ¼Ö·ç¼ÇÀ» °³¹ßÇÏ¿© COVID-19 »çŸ¦ ¸·±â À§ÇÑ Á¤ºÎÀÇ ³ë·ÂÀ» Áö¿øÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº COVID-19°¡ ºñÁî´Ï½º¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀÏ ¼ö ÀÖ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, À¯·ÎÇɽº ¿¬±¸¼Ò´Â 4,000¸¸ °³ÀÇ COVID-19 °Ë»ç ŰƮ¸¦ ¼º°øÀûÀ¸·Î »ý»êÇß½À´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ º¯Á¾¿¡ ´ëÇÑ »õ·Î¿î °Ë»ç ŰƮ¸¦ ¸¸µé°í ÀÖÀ¸¸ç, WHO°¡ COVID-19¸¦ ¿ì·ÁÇÒ ¸¸ÇÑ º¯Á¾À¸·Î ºÐ·ùÇßÀ» ¶§ Áï½Ã ¿À¹ÌÅ©·Ð °Ë»ç ŰƮ¸¦ Ãâ½ÃÇß½À´Ï´Ù.

¹Ì±¹ÀÇ ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®:

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå : ¼­ºñ½º ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ ÀǾàǰ ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends:

The U.S. pharmaceutical analytical testing outsourcing market size is expected to reach USD 5.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 8.5% from 2025 to 2030. Technological advancements in the healthcare industry and an increase in end-users are the key factors driving the growth of the U.S. market.

Analytical testing services outsourcing allows companies to handle more complex or repetitive tasks while also assisting companies in concentrating on their core competencies. Enabling medical organizations to avoid developing specialized facilities and hiring staff, results in cost savings. The identification and measurement of ingredients in drugs or therapeutic solutions are included in pharmaceutical analytical testing. The market is anticipated to expand during the assessment period as a result of rising R&D investments and rising drug demand.

The outsourcing of pharmaceutical analytical testing has been significantly impacted by the COVID-19 pandemic. Due to various pharmaceutical companies' internal lab testing capacities being reduced or shut down, the pharmaceutical analytical services-an important component of the healthcare infrastructure-were initially disrupted. The workers initially faced several difficulties, including reduced lab capacity because of concerns about spreading the virus, IT issues, and difficulties sending samples for testing. However, various strategies, including rotating shifts, reducing manpower, and working from home, have been adopted by companies to mitigate or prevent these difficulties.

Various companies supported the government's efforts to stop the COVID-19 pandemic by producing various cutting-edge tests and solutions. These businesses were able to reduce the effects of COVID-19 on their operations. For example, 40 million COVID-19 tests were successfully manufactured by Eurofins laboratories. Additionally, new test kits are being created for various variants. When WHO classified it as a variant of concern, they released an omicron test kit the same day.

U.S. Pharmaceutical Analytical Testing Outsourcing Market Report Highlights:

Table of Contents

Chapter 1. Research Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope

Chapter 4. U.S. Pharmaceutical Analytical Testing Outsourcing Market: Services Estimates & Trend Analysis

Chapter 5. U.S. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis

Chapter 6. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â